Suppression of induced inflammation in man.
Kerscher
M J
MJ
Department of Dermatology, Ludwig Maximilian University, Munich, FRG.
D000279:Administration, Cutaneous; D000328:Adult; D001624:Betamethasone Valerate / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D004341:Drug Evaluation / Q000379:methods*; D004890:Erythema / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012867:Skin / Q000098:blood supply / Q000187:drug effects* / Q000528:radiation effects; D014466:Ultraviolet Rays / Q000009:adverse effects; D014661:Vasoconstriction / Q000187:drug effects
C063919:hydrocortisone aceponate; C033014:hydrocortisone 17-butyrate 21-propionate; D001624:Betamethasone Valerate; D011239:Prednisolone; C035287:prednicarbate; D006854:Hydrocortisone